Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage

F.E. van Leeuwen, A.M.J. Chorus, A.W. van den Belt-Dusebout, A. Hagenbeek, R. van Noyon, E.H.M. Kerkhoff, H.M. Pinedo, R. Somers

Research output: Contribution to journalArticleAcademicpeer-review

43 Downloads (Pure)
Original languageEnglish
Pages (from-to)1063-1073
JournalJournal of Clinical Oncology
Volume12
Issue number5
Publication statusPublished - 1994

Cite this

van Leeuwen, F. E., Chorus, A. M. J., van den Belt-Dusebout, A. W., Hagenbeek, A., van Noyon, R., Kerkhoff, E. H. M., ... Somers, R. (1994). Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. Journal of Clinical Oncology, 12(5), 1063-1073.